ArticleDNA repair2026
B cell receptor stimulation inhibits class switch recombination through elevated DNA repair.
Article in DNA repair, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Antibody diversity in B cells arises from the activity of activation-induced deaminase (AID), which introduces uracils into DNA of the immunoglobulin loci. The presence of uracil initiates a cascade of mutagenic events, resulting in somatic hypermutation and class switch recombination (CSR). To produce CSR, uracils are removed from DNA by uracil DNA glycosylase (UNG), resulting in formation of an abasic site, which is subsequently transformed into a double-stand break and promotes recombination to another constant gene. While the classical model indicates that B cells are activated when the IgM receptor binds antigen, stimulation of cells ex vivo with anti-IgM is insufficient for CSR. In fact, anti-IgM stimulation has a strong inhibitory effect on CSR when added together with lipopolysaccharide (LPS). To determine the mechanism of anti-IgM inhibition of CSR, we examined the known components required for CSR: AID and UNG. After stimulation with anti-IgM and LPS, AID was expressed and recruited to the immunoglobulin loci, and UNG levels increased and prevented uracil accumulation. We also linked the increased expression of UNG to the cell-cycle, as the presence of anti-IgM allowed cells to enter S-phase sooner. Therefore, for efficient CSR, AID-induced uracils must accumulate to sufficient levels before initiating S-phase, to provide more substrate for UNG and endonuclease to generate mutagenic strand breaks. If cell division occurs too early, as in the case of stimulation with anti-IgM and LPS, UNG is quickly upregulated and removes the uracils before they can accumulate, resulting in faithful DNA repair and less CSR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.